SAREPTA THERAPEUTICS, INC. Investment Income, Interest
SAREPTA THERAPEUTICS, INC. (SRPT) reported Investment Income, Interest of $6.21 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-05
- SAREPTA THERAPEUTICS, INC. investment income, interest for the quarter ending 2026-06-30 was $6.21M, a 18.14% increase year-over-year.
- SAREPTA THERAPEUTICS, INC. investment income, interest for the quarter ending 2026-03-31 was $6.36M, a 37.59% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. investment income, interest for the quarter ending 2025-12-31 was $8.07M, a 2.39% increase year-over-year.
- SAREPTA THERAPEUTICS, INC. investment income, interest for the quarter ending 2025-09-30 was $7.25M, a 4.42% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. investment income, interest for fiscal 2025 was $30.76M, a 0.42% increase from fiscal 2024.
- SAREPTA THERAPEUTICS, INC. investment income, interest for fiscal 2024 was $30.64M, a 15.51% decline from fiscal 2023.
- SAREPTA THERAPEUTICS, INC. investment income, interest for fiscal 2023 was $36.26M, a 119.90% increase from fiscal 2022.
- SAREPTA THERAPEUTICS, INC. investment income, interest for fiscal 2022 was $16.49M, a 4557.63% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.21M 10-Q · filed 2026-08-05 | $12.57M 10-Q · filed 2026-08-05 | $20.64M derived: sum of 3 quarters · filed 2026-08-05 | $27.89M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $6.36M 10-Q · filed 2026-05-06 | $14.43M derived: sum of 2 quarters · filed 2026-05-06 | $21.68M derived: sum of 3 quarters · filed 2026-05-06 | $26.93M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $8.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $15.32M derived: sum of 2 quarters · filed 2026-03-02 | $20.57M derived: sum of 3 quarters · filed 2026-08-05 | $30.76M 10-K · filed 2026-03-02 |
| 2025-09-30 | $7.25M 10-Q · filed 2025-11-06 | $12.50M derived: sum of 2 quarters · filed 2026-08-05 | $22.69M 10-Q · filed 2025-11-06 | $30.57M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $5.25M 10-Q · filed 2026-08-05 | $15.44M 10-Q · filed 2026-08-05 | $23.33M derived: sum of 3 quarters · filed 2026-08-05 | $30.91M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $10.19M 10-Q · filed 2026-05-06 | $18.07M derived: sum of 2 quarters · filed 2026-05-06 | $25.66M derived: sum of 3 quarters · filed 2026-05-06 | $33.73M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $7.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $15.47M derived: sum of 2 quarters · filed 2026-03-02 | $23.54M derived: sum of 3 quarters · filed 2026-03-02 | $30.64M 10-K · filed 2026-03-02 |
| 2024-09-30 | $7.58M 10-Q · filed 2025-11-06 | $15.66M derived: sum of 2 quarters · filed 2025-11-06 | $22.75M 10-Q · filed 2025-11-06 | $31.48M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $8.08M 10-Q · filed 2025-08-06 | $15.17M 10-Q · filed 2025-08-06 | $23.89M derived: sum of 3 quarters · filed 2026-03-02 | $33.73M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | $7.09M 10-Q · filed 2025-05-06 | $15.82M derived: sum of 2 quarters · filed 2026-03-02 | $25.66M derived: sum of 3 quarters · filed 2026-03-02 | $34.07M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $8.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $18.56M derived: sum of 2 quarters · filed 2026-03-02 | $26.98M derived: sum of 3 quarters · filed 2026-03-02 | $36.26M 10-K · filed 2026-03-02 |
| 2023-09-30 | $9.84M 10-Q · filed 2024-11-06 | $18.26M derived: sum of 2 quarters · filed 2024-11-06 | $27.53M 10-Q · filed 2024-11-06 | $36.66M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $8.42M 10-Q · filed 2024-08-07 | $17.69M 10-Q · filed 2024-08-07 | $26.82M derived: sum of 3 quarters · filed 2025-02-28 | $31.60M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $9.28M 10-Q · filed 2024-05-01 | $18.40M derived: sum of 2 quarters · filed 2025-02-28 | $23.18M derived: sum of 3 quarters · filed 2025-02-28 | $25.59M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $9.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $13.91M derived: sum of 2 quarters · filed 2025-02-28 | $16.32M derived: sum of 3 quarters · filed 2025-02-28 | $16.49M 10-K · filed 2025-02-28 |
| 2022-09-30 | $4.78M 10-Q · filed 2023-11-01 | $7.19M derived: sum of 2 quarters · filed 2023-11-01 | $7.36M 10-Q · filed 2023-11-01 | $7.46M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $2.41M 10-Q · filed 2023-08-02 | $2.58M 10-Q · filed 2023-08-02 | $2.68M derived: sum of 3 quarters · filed 2024-02-28 | $2.83M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $173.00K 10-Q · filed 2023-05-02 | $268.00K derived: sum of 2 quarters · filed 2024-02-28 | $416.00K derived: sum of 3 quarters · filed 2024-02-28 | $468.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $243.00K derived: sum of 2 quarters · filed 2024-02-28 | $295.00K derived: sum of 3 quarters · filed 2024-02-28 | $354.00K 10-K · filed 2024-02-28 |
| 2021-09-30 | $148.00K 10-Q · filed 2022-11-02 | $200.00K derived: sum of 2 quarters · filed 2022-11-02 | $259.00K 10-Q · filed 2022-11-02 | $330.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $52.00K 10-Q · filed 2022-08-02 | $111.00K 10-Q · filed 2022-08-02 | $182.00K derived: sum of 3 quarters · filed 2023-02-28 | $304.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $59.00K 10-Q · filed 2022-05-04 | $130.00K derived: sum of 2 quarters · filed 2023-02-28 | $252.00K derived: sum of 3 quarters · filed 2023-02-28 | $890.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $193.00K derived: sum of 2 quarters · filed 2023-02-28 | $831.00K derived: sum of 3 quarters · filed 2023-02-28 | $2.97M 10-K · filed 2023-02-28 |
| 2020-09-30 | $122.00K 10-Q · filed 2021-11-03 | $760.00K derived: sum of 2 quarters · filed 2021-11-03 | $2.90M 10-Q · filed 2021-11-03 | $4.38M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $638.00K 10-Q · filed 2021-08-04 | $2.78M 10-Q · filed 2021-08-04 | $4.26M derived: sum of 3 quarters · filed 2022-03-01 | $5.55M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $2.14M 10-Q · filed 2021-05-05 | $3.62M derived: sum of 2 quarters · filed 2022-03-01 | $4.91M derived: sum of 3 quarters · filed 2022-03-01 | $7.02M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $2.77M derived: sum of 2 quarters · filed 2022-03-01 | $4.88M derived: sum of 3 quarters · filed 2022-03-01 | $7.24M 10-K · filed 2022-03-01 |
| 2019-09-30 | $1.29M 10-Q · filed 2020-11-05 | $3.40M derived: sum of 2 quarters · filed 2020-11-05 | $5.76M 10-Q · filed 2020-11-05 | $7.33M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $2.10M 10-Q · filed 2020-08-05 | $4.46M 10-Q · filed 2020-08-05 | $6.04M derived: sum of 3 quarters · filed 2021-03-01 | $7.52M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $2.36M 10-Q · filed 2020-05-06 | $3.94M derived: sum of 2 quarters · filed 2021-03-01 | $5.41M derived: sum of 3 quarters · filed 2021-03-01 | $7.30M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $3.05M derived: sum of 2 quarters · filed 2021-03-01 | $4.94M derived: sum of 3 quarters · filed 2021-03-01 | $6.81M 10-K · filed 2021-03-01 |
| 2018-09-30 | $1.48M 10-Q · filed 2019-11-07 | $3.36M derived: sum of 2 quarters · filed 2019-11-07 | $5.24M 10-Q · filed 2019-11-07 | $6.23M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $1.89M 10-Q · filed 2019-08-07 | $3.76M 10-Q · filed 2019-08-07 | $4.75M derived: sum of 3 quarters · filed 2020-02-26 | $5.19M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $1.87M 10-Q · filed 2019-05-08 | $2.87M derived: sum of 2 quarters · filed 2020-02-26 | $3.31M derived: sum of 3 quarters · filed 2020-02-26 | $3.50M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $996.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $1.43M derived: sum of 2 quarters · filed 2020-02-26 | $1.62M derived: sum of 3 quarters · filed 2020-02-26 | $1.81M 10-K · filed 2020-02-26 |
| 2017-09-30 | $438.00K 10-Q · filed 2018-10-31 | $627.00K derived: sum of 2 quarters · filed 2018-10-31 | $813.00K 10-Q · filed 2018-10-31 | |
| 2017-06-30 | $189.00K 10-Q · filed 2018-08-08 | $375.00K 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | $186.00K 10-Q · filed 2018-05-03 | |||
| 2016-12-31 | $507.00K 10-K · filed 2019-02-28 | |||
| 2015-12-31 | $890.00K 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |